PET scans reveal how inflammation drives Alzheimer's variants

NCT ID NCT04576793

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study uses special PET scans to measure brain inflammation and tau protein buildup in people with different forms of Alzheimer's disease, including those with memory, vision, or language problems. Researchers aim to understand how inflammation relates to other brain changes and symptoms over time. Participants include older adults with mild cognitive impairment, Alzheimer's variants, and healthy volunteers.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
11C-ER176 and 18F-MK6240 (radioactive tracers for PET scans)
What this could lead to
If successful, this could clarify how brain inflammation relates to Alzheimer's progression and symptoms, potentially guiding future treatments.
What could go wrong
This is an observational imaging study, not a treatment trial. The tracers are experimental and may not reliably measure inflammation or tau across all participants.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Columbia University Irving Medical Center

    RECRUITING

    New York, New York, 10032, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.